Companies

Mylan Inc.

NASDAQ: MYL
$15.86
â–² $0.00 (+0.00%) today
Markets closed · 8:03pm ET

MYL Coverage

Page 11
4:02pm ET
Health and Healthcare

The Generic Boniva Opportunity (RHHBY, MYL)

The Food and Drug Administration approval of the first generic versions of osteoporosis drug Boniva won’t be the end of Roche Holding AG (OTC: RHHBY) for its marketing of Boniva in the United States. …

MYL
Jon C. Ogg
6:18am ET
Investing

Short Sellers Move Into Financials, Out Of Tech

Short sellers moved into the shares of large financial firms, perhaps sensing the effects of new regulation and an exit from proprietary trading businesses. The short interest in Citigroup (NYSE: C) rose…

Douglas A. McIntyre
11:40am ET
Health and Healthcare

Mylan’s (MYL) Deeply Flawed Legal And PR Move

Robert Coury, the CEO of Mylan (MYL), his general counsel, and public affairs staff don’t know how to quit when they are ahead. The company objected to a story in the Pittsburgh…

MYL
Douglas A. McIntyre